Jerry J. Markar

Jerry Markar practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Jerry Markar's NPI, 1083145320, was assigned on March 27, 2017. Jerry Markar graduated from University of Illinois College of Medicine - Chicago in 2017. Jerry Markar holds California license A160041.

Jerry Markar's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Jerry Markar's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is UCLA Health / UCLA Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Jerry Markar practices. Vendor and product names are available with a free account.

Anesthesiology is Jerry Markar's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Jerry Markar is board certified in anesthesiology by the American Board of Anesthesiology. Jerry Markar is licensed in California.

Dmand AI lists back pain injection, drug use disorders, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Jerry Markar treats.

CMS data shows 1,025 Medicare services from Jerry Markar across 7 procedure codes in 2024, for 262 Medicare patients. Medicare paid $90,327 for them.

CMS counts 262 Medicare patients who saw Jerry Markar in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have arthritis, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jerry Markar's median patient age at 60, with 61% women.

In 2024, Jerry Markar wrote 913 Medicare Part D claims for 174 patients. 97% of them were for generic drugs. CMS names the drug for 866 of them, across 15 drugs with 11 or more claims each, at $18,570 in total drug cost. In 2023, CMS named 502 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Jerry Markar for performance year 2024, reported as part of a group. Jerry Markar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jerry Markar as offering telehealth.

Dmand AI links 1 paper to Jerry Markar in 2025. Jerry Markar's most frequent co-authors are Bi Mo and Sandra Hsu Sacks, MD.

CMS Open Payments shows 50 general payments to Jerry Markar from 15 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 64% of the total. Boston Scientific Corporation paid the most, $3,333.

Jerry Markar graduated from University of Illinois College of Medicine - Chicago in 2017. Jerry Markar is a member of AOA.

Jerry Markar is in network with 3 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.